NDC 0024-5824

Jevtana

Cabazitaxel

Jevtana is a Kit in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is .

• Product ID: 0024-5824_30e263c2-3a06-4481-af0a-78a2a8156611
• NDC: 0024-5824
• Product Type: Human Prescription Drug
• Proprietary Name: Jevtana
• Generic Name: Cabazitaxel
• Dosage Form: Kit
• Marketing Start Date: 2010-06-17
• Marketing Category: NDA / NDA
• Application Number: NDA201023
• Labeler Name: Sanofi-Aventis U.S. LLC
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0024-5824-11

1 KIT in 1 CARTON (0024-5824-11) * 5.7 mL in 1 VIAL, GLASS (0024-5823-15) * 5.7 mL in 1 VIAL, GLASS (0024-5822-01)

• Marketing Start Date: 2010-06-17
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0024-5824-11 [00024582411]

Jevtana KIT

• Marketing Category: NDA
• Application Number: NDA201023
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2010-06-17

Drug Details

OpenFDA Data

• SPL SET ID: de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa
• Manufacturer:
  • Sanofi-Aventis U.S. LLC
• RxNorm Concept Unique ID - RxCUI:
  • 1376084
  • 1001433